KURA
Kura Oncology Inc
$18.19
Earnings Summary
Revenue | $1.27Mn |
Net Profits | $-42.79Mn |
Net Profit Margins | -3368.98% |
Highlights
Kura Oncology Inc’s revenue jumped +Inf% since last year same period to $1.27Mn in the Q4 2023. On a quarterly growth basis, Kura Oncology Inc has generated +Inf% jump in its revenue since last 3-months.
Kura Oncology Inc’s net profit fell -28.32% since last year same period to $-42.79Mn in the Q4 2023. On a quarterly growth basis, Kura Oncology Inc has generated -10.84% fall in its net profits since last 3-months.
Kura Oncology Inc’s net profit margin jumped NaN% since last year same period to -3368.98% in the Q4 2023. On a quarterly growth basis, Kura Oncology Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Kura Oncology Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.55 |
EPS Estimate Current Year | -0.55 |
Highlights
Kura Oncology Inc’s earning per share (EPS) estimates for the current quarter stand at -0.55 - a 0% jump from last quarter’s estimates.
Kura Oncology Inc’s earning per share (EPS) estimates for the current year stand at -0.55.
Key Ratios
Key ratios of the Kura Oncology Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.55 |
Highlights
Kura Oncology Inc’s earning per share (EPS) fell -12.24% since last year same period to -0.55 in the Q4 2023. This indicates that the Kura Oncology Inc has generated -12.24% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-02-27 | -0.55 | -0.55 | 0% |
2023-08-09 | -0.55 | -0.53 | 3.64% |
2023-11-02 | -0.55 | -0.5 | 9.09% |
2023-05-10 | -0.54 | -0.5 | 7.41% |
₹0 US Stocks a/c Opening Fee